Streetbeat News

Regulatory

PLUG

Plug Power plans to leverage the Inflation Reduction Act's Section 45V credit for clean hydrogen production in its upcoming quarterly financial reports. The company aims to utilize this framework to enhance its hydrogen generation facilities across the U.S.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:07 am

DJT

Trump Media & Technology Group (NASDAQ:DJT) shares soared premarket following the first 2024 presidential debate between President Joe Biden and former President Donald Trump. Biden's performance raised concerns about his age, while Trump reiterated his election denialism. The court's rejection of a bid to limit White House interactions with social media companies also impacted DJT's stock.

Portfolio Pulse from Anusuya Lahiri

June 28, 2024 | 11:04 am

REGN

Regeneron Pharmaceuticals announced that the EMA's CHMP has adopted a positive opinion recommending conditional marketing authorization of odronextamab for treating relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma. The final decision by the European Commission is expected in the coming months.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:04 am

ICE

Intercontinental Exchange, Inc. announced that its subsidiary, ICE Benchmark Administration Limited, has provided an update on the cessation of U.S. dollar LIBOR.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:03 am

MRK

The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of Merck's Winrevair (Sotatercept) for use in combination with other therapies for pulmonary arterial hypertension (PAH) in adult patients. The European Commission's decision is expected in Q3.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:02 am

APLS

Apellis Pharmaceuticals announced that it plans to seek re-examination following a negative opinion from the Committee for Medicinal Products for Human Use (CHMP) regarding its drug Pegcetacoplan for the treatment of geographic atrophy in the EU.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 11:01 am

MRNA

VGK

Moderna's mResvia received a positive opinion from the CHMP for the prevention of lower respiratory tract disease and acute respiratory disease caused by respiratory syncytial virus in adults aged 60 and older.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 10:58 am

RCKT

Trading in RCKT was halted at 6:56:37 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 10:56 am

RCKTW

Trading in RCKTW has been halted as of 6:56:37 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 10:56 am

JNJ

VGK

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Janssen's Eurneffy (Epinephrine), the first emergency treatment for allergic reactions administered as a nasal spray.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 10:55 am